Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.
Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney
Ven PV, Mao L, Fogarty A, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS. 2005;19:179-184.
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The Resistance and Dosage Adapted Regimens (RADAR) study
Torti C, Quiros-Roldan E, Regazzi M, et al. A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study. Clin Infect Dis. 2005;40:1828-1836.
Communication of HIV viral load to make sexual risk decisions with serodiscordant partners among a diverse sample of men who have sex with men
June 12-15; Atlanta. Abstract TP-113
Guzman R et al. Communication of HIV viral load to make sexual risk decisions with serodiscordant partners among a diverse sample of men who have sex with men. Presented at the 2005 National HIV Prevention Conference; June 12-15, 2005; Atlanta. Abstract TP-113.
Beliefs about viral load, sexual positioning and transmission risk among HIV+ men who have sex with men (MSM): Shaping a secondary prevention intervention
June 12-15; Atlanta. Abstract W0-D1201
Goldhammer H et al. Beliefs about viral load, sexual positioning and transmission risk among HIV+ men who have sex with men (MSM): shaping a secondary prevention intervention. Presented at the 2005 National HIV Prevention Conference; June 12-15, 2005; Atlanta. Abstract W0-D1201.
Common-sense serum: While AIDS testing and counseling are crucial, the only effective vaccine is a change in risky behavior
June 15
Common-sense serum: while AIDS testing and counseling are crucial, the only effective vaccine is a change in risky behavior [editorial]. Atlanta Journal-Constitution. June 15, 2005:A14.
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy
Nicastri E, Angeletti C, Palmisano L, et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS. 2005;19:577-583.